LESLIE FARR: Open Payments
NPI 1770829079 · MECHANICSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 32 payments from 10 companies in 2025. Trend: 2023 $337 · 2024 $189 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $174 |
| Incyte Corporation | 3 | $83 |
| GENZYME CORPORATION | 2 | $71 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Amgen Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, OPZELURA, Zoryve, OTEZLA, COSENTYX, YCANTH, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
